Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00508703 · ClinicalTrials.gov registry record
Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 24
- Enrollment target
NCT00508703: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00508703 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00508703 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to use CT scans to find any changes in position of the vagina and pelvic lymph node areas during the course of IMRT radiation therapy. Treatment can then be adjusted in order to "spare" as much normal tissue as possible during radiation therapy. Another goal is to study the side effects of IMRT radiation therapy.
Interventions
- PROCEDURE CT Scan
- RADIATION Intensity Modulated Radiotherapy (IMRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2003-03-05 |
| Est. Completion | 2017-09-08 |
What the finished NCT00508703 record still lists
NCT00508703 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which CT Scan is the first listed.
NCT00508703 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00508703 about?
NCT00508703 is a clinical study titled "Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy". The goal of this clinical research study is to use CT scans to find any changes in position of the vagina and pelvic lymph node areas during the course of IMRT radiation therapy. Treatment can then be adjusted in order to "spare" as much normal tissue as possible during radiation therapy. Another go...
What is the current status of trial NCT00508703?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2003-03-05. Estimated completion is 2017-09-08.
What interventions are being tested in trial NCT00508703?
The interventions under investigation include: CT Scan (PROCEDURE), Intensity Modulated Radiotherapy (IMRT) (RADIATION).
Who is sponsoring clinical trial NCT00508703?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI